CITADEL ADVISORS LLC
What you'd have made by mirroring CITADEL ADVISORS LLC's public 13F filings, starting with $10,000 on Aug 14, 2024 and rebalancing at every disclosure through May 31, 2026.
Equity curve
$10,000 mirrored · vs SPYRisk profile
Weekly mirror returns vs SPY · rf ≈ 4%Drawdown
Underwater curve — distance below running peakLargest drawdown: -14.9% from 2024-12-04 to 2025-04-16 · recovered 2025-07-23.
Style decomposition
R² 49% · 94 weekly obsMultivariate regression of weekly mirror excess return on five style factors built from the benchmark ETFs: SPY (market), IWM−SPY (size), QQQ−SPY (growth), EFA−SPY (international), AGG−SPY (bonds). The intercept is the “true alpha” after stripping these passive tilts. ✓ marks loadings whose |t-stat| ≥ 2 (≈ 95% confidence the loading is non-zero).
Rolling 1y alpha
Trailing 52w mirror return − SPY returnWhether the headline alpha was earned recently or decades ago. Bands above the zero line are quarters where the mirror beat SPY on a trailing-year basis; bands below are quarters where it lost ground. A flat positive line = steady outperformance; a curve that crosses often = regime-dependent strategy.
Realized P&L · closed trades
Cumulative profit from positions opened and later soldBiggest closed trades
| Issuer | Entry | Exit | Held | Return | P&L |
|---|---|---|---|---|---|
MERCK & CO INC MRK | Q3 2024 | Q3 2025 | 4Q | -25% | −$251.77M |
NEXTRACKER INC NXT | Q3 2024 | Q1 2026 | 6Q | +220% | +$136.17M |
ACADIA HEALTHCARE COMPANY IN ACHC | Q3 2024 | Q3 2025 | 4Q | -72% | −$115.38M |
GOLDMAN SACHS GROUP INC GS | Q3 2024 | Q1 2025 | 2Q | +34% | +$100.78M |
BOOKING HOLDINGS INC BKNG | Q3 2024 | Q3 2025 | 4Q | +55% | +$97.07M |
BRIDGEBIO PHARMA INC BBIO | Q3 2024 | Q4 2025 | 5Q | +174% | +$94.92M |
SHOPIFY INC SHOP | Q3 2024 | Q3 2025 | 4Q | +102% | +$90.21M |
US FOODS HLDG CORP USFD | Q3 2024 | Q1 2026 | 6Q | +74% | +$76.71M |
LPL FINL HLDGS INC LPLA | Q3 2024 | Q2 2025 | 3Q | +76% | +$76.17M |
WINGSTOP INC WING | Q3 2025 | Q2 2026 | 3Q | -60% | −$72.11M |